Researchers Identify Novel Therapeutic Targets for Small Cell Lung Cancer

Results of a new study indicate that the newly discovered molecular differences between small cell lung cancer and nonsmall cell lung cancer have revealed PARP1 and EZH2 as potential therapeutic targets for patients with small cell lung cancer. The study is published in iCancer Discovery/i, a journal of the American Association for Cancer Research. Currently, small cell lung cancer accounts for about 15 percent of lung cancer diagnoses in the United States. Patients with the disease will ...